Shares of peptide specialty company ANYGEN are strong in early trading on the 11th. It is interpreted that buying interest surged due to news of HLB Group's acquisition of ANYGEN. The share price of ANYGEN has risen more than 70% over the last three trading days.
As of 9:55 a.m. on that day, ANYGEN is trading at 12,420 won, up 1,080 won (9.52%) from the previous trading day.
After the market closed the previous day, HLB Group announced that it would acquire ANYGEN. This is interpreted as a sign of strength in the share price.
Even before the announcement, the share price of ANYGEN was on an upward trend. From the 6th to the previous day, it rose more than 75% over three trading days.
Considering the upward trend on that day, ANYGEN surged nearly 90% over the four trading days. The share price, which was in the 5,000 won range on the 5th, has surpassed the 10,000 won level.
With this acquisition of ANYGEN by HLB Group, HLB Group is set to significantly enhance its capabilities in the development and production of peptide-based pharmaceuticals. ANYGEN is the only company in South Korea that possesses a factory certified for good manufacturing practice (GMP) for the production of peptide-based pharmaceuticals.